ProductsPricingFree Market DashboardMarket News FeedScannerChartsHeatmapMarket SectorsTrack RecordMAD AcademyMCP Connector

BioMarin Pharmaceuticals Inc (BMRN)

Nasdaq · Common stock · Pharmaceutical Preparations

$55.86-0.59 (-1.04%)

As of Oct 21, 2:18 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.

Follow BMRN in real time

Real-time quotes, Pro Charting, the scanner and the alert feed on BMRN and every other US listing.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Or open the free BMRN chart →

BMRN at a glance

Key statistics

$10.93B

Market capitalization

Previous close
$56.44
Open
$56.43
Day range
$55.55 – $56.85
Volume
1.01M
Average volume (30 sessions)
2.30M
Shares outstanding
193.57M
Price / earnings
149.7
Earnings per share
$0.38
Price / book
1.7
Price / sales
3.2
Beta (1 year, vs SPY)
0.37

Where the price sits in its year

52-week range

30% of the range

Below the 52-week high
-21.3%
Above the 52-week low
+13.4%

Completed sessions through Oct 20, 2026

Technical snapshot

Below its 50-day and 200-day averages

20-day average
$57.21-1.3%
50-day average
$62.52-9.7%
200-day average
$58.52-3.6%
RSI (14)41.6

Between the conventional 30 and 70 bands.

+3.8%

1 week

-11.9%

1 month

-3.4%

3 months

-5.0%

Year to date

+5.9%

1 year

Price change over each window, from completed sessions. Past performance does not indicate future results.

Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.

The member platform, in real time

What members do with BMRN

Every plan

BMRN on Pro Charting

Every intraday interval in real time, the drawing kit and the full set of technical studies on BMRN.

See the plans →

Every plan

Screen names like BMRN

The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.

See the plans →

Analysis Tools Only

Set a price line on BMRN

Put BMRN on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.

See the plans →

Stock Alerts + Tools

Open alerts on BMRN

See whether there is an open premium alert on BMRN, with its entry, stop and exit, each one reviewed by an analyst before it is sent.

See the plans →

From the public news wire

BMRN headlines

Market news →

SEC Form 4, most recent first

Insider filings

How to read these →

  • Friberg Gregory R

    −4.1K

    EVP, Chief R&D Officer · Shares withheld for tax

    $245.16K · Sep 30, 2026

  • Plenge Robert M

    +6.1K

    Director · Grant or award

    · Sep 10, 2026

  • Davis George Eric

    −17.6K

    EVP, Chief Legal Officer · Open-market sale

    $1.16M · Sep 2, 2026

  • Bodem Barbara W.

    +7.5K

    Director · Grant or award

    · Jun 2, 2026

  • Enyedy Mark J

    +7.5K

    Director · Grant or award

    · Jun 2, 2026

  • HOMBACH ROBERT J.

    +7.5K

    Director · Grant or award

    · Jun 2, 2026

  • Countouriotis Athena

    +7.5K

    Director · Grant or award

    · Jun 2, 2026

  • Dere Willard H

    +7.5K

    Director · Grant or award

    · Jun 2, 2026

About BioMarin Pharmaceuticals Inc

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Exchange
Nasdaq
Security
Common stock
Industry
Pharmaceutical Preparations
Headquarters
Novato, CA
Employees
3,221
Listed since
Jul 23, 1999
Website
biomarin.com
Educational content only. MadStockAlerts provides market commentary, research, and educational content. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security. Trading and investing involve substantial risk, including loss of capital. See the Risk Disclosure and Customer Agreement.

Pick the desk that fits how you trade

Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.